COLOMBO, Paolo
 Distribuzione geografica
Continente #
AS - Asia 12.644
NA - Nord America 12.592
EU - Europa 7.897
SA - Sud America 1.609
AF - Africa 515
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 28
Totale 35.314
Nazione #
US - Stati Uniti d'America 12.252
SG - Singapore 4.485
CN - Cina 3.992
VN - Vietnam 1.769
IE - Irlanda 1.442
FI - Finlandia 1.384
BR - Brasile 1.280
SE - Svezia 1.205
HK - Hong Kong 852
UA - Ucraina 834
DE - Germania 802
IT - Italia 716
TR - Turchia 493
FR - Francia 405
ZA - Sudafrica 390
NL - Olanda 372
GB - Regno Unito 265
BD - Bangladesh 243
CA - Canada 225
IN - India 163
RU - Federazione Russa 150
AR - Argentina 136
KR - Corea 116
MX - Messico 76
IQ - Iraq 72
AT - Austria 51
JP - Giappone 51
PK - Pakistan 50
ES - Italia 48
EC - Ecuador 46
ID - Indonesia 44
PH - Filippine 44
BE - Belgio 43
PL - Polonia 43
CO - Colombia 39
UZ - Uzbekistan 37
MA - Marocco 31
TW - Taiwan 31
CZ - Repubblica Ceca 29
TH - Thailandia 29
VE - Venezuela 27
EU - Europa 26
IR - Iran 23
AU - Australia 22
PY - Paraguay 22
CL - Cile 20
JO - Giordania 20
MY - Malesia 20
UY - Uruguay 17
KE - Kenya 16
PE - Perù 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 15
EG - Egitto 14
IL - Israele 13
LT - Lituania 13
PT - Portogallo 13
SA - Arabia Saudita 13
AZ - Azerbaigian 12
AL - Albania 11
ET - Etiopia 11
RO - Romania 10
RS - Serbia 10
TN - Tunisia 10
KZ - Kazakistan 9
SN - Senegal 8
HN - Honduras 7
HR - Croazia 7
BG - Bulgaria 6
BY - Bielorussia 6
YE - Yemen 6
BO - Bolivia 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
GA - Gabon 5
LB - Libano 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
BH - Bahrain 4
CH - Svizzera 4
CR - Costa Rica 4
GR - Grecia 4
JM - Giamaica 4
MD - Moldavia 4
NO - Norvegia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
DK - Danimarca 2
EE - Estonia 2
Totale 35.280
Città #
Singapore 2.085
Dublin 1.440
Ashburn 1.419
Chandler 1.342
San Jose 1.299
Beijing 1.030
Jacksonville 1.003
Santa Clara 849
Hong Kong 813
Dearborn 540
Ho Chi Minh City 523
Nanjing 474
Boardman 425
Dallas 422
Hanoi 413
Izmir 398
Johannesburg 375
Princeton 314
Lauterbourg 271
Ann Arbor 252
Los Angeles 244
San Mateo 239
Parma 205
Wilmington 201
Hefei 200
Shanghai 186
Shenyang 175
Helsinki 155
New York 148
Kunming 147
Nanchang 140
Munich 135
Toronto 135
Jinan 132
Hebei 119
São Paulo 117
Moscow 105
Buffalo 95
Jiaxing 84
Seoul 84
Columbus 81
Tianjin 80
Bremen 79
Guangzhou 74
Woodbridge 74
Changsha 73
Council Bluffs 72
Da Nang 71
Seattle 71
The Dalles 71
Grafing 70
Haiphong 70
Marseille 64
Des Moines 62
Milan 57
Zhengzhou 49
Brooklyn 47
Houston 44
Turku 43
Kocaeli 41
Brussels 39
Vienna 38
London 36
Rio de Janeiro 36
Norwalk 35
Orem 34
Rome 34
Stockholm 32
Warsaw 31
Chennai 30
Brasília 29
Tashkent 29
Bologna 28
Phoenix 28
Pune 28
San Francisco 28
Tokyo 28
Belo Horizonte 27
Frankfurt am Main 27
Hải Dương 27
Ningbo 27
Atlanta 26
Can Tho 26
Fremont 26
Hangzhou 26
Montreal 26
Brno 25
Jakarta 24
Baghdad 23
Curitiba 23
Chengdu 22
Chicago 22
Amsterdam 20
Haikou 20
Poplar 20
Denver 19
Manchester 19
Mexico City 19
Amman 18
Biên Hòa 18
Totale 21.099
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
A process and an apparatus for administering a predefined amount of a compound 241
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 225
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 203
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 203
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 202
Mechanisms of formation and disintegration of alginate beads obtained by prilling 188
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport 184
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 179
Alginate containing formulations: are they all the same? 179
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 174
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 173
MULTILAYERED PHARMACEUTICAL FORMULATION 172
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 170
Solid-state characterization of tobramycin powders for inhalation 170
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 168
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 167
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 166
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 166
Assemblage of novel release modules for the development of adaptable drug delivery systems 165
Bioadhesive film for dermal and transdermal drug delivery” 163
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 162
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport 162
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 161
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 161
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 160
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 160
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 160
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 159
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 159
Validation of a clean-in-place system on a capsule filling machine 157
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 156
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 153
Bioadhesive transdermal film containing caffeine 152
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 152
A drug powder for inhalation administration and a process thereof 151
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 151
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 150
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 149
A novel spray dried formulation for pulmonary administration of insulin 149
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 149
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 149
A DRUG POWDER FOR INHALATION ADMINISTRATION AND PROCESS THEREOF 148
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 148
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 148
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 147
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 147
Flexibility and drug release features of lipid/saccharide nanoparticles 147
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 147
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 146
Crystalline Microparticles of a Beta-Agonist Coated with a Fatty Acid 145
A rheometric method for assessing the sucralfate mucin interaction 145
Film for active ingredients dermal and transdermal administration 144
The Surface Roughness of Lactose Particles Can Be Modulated by Wet- Smoothing Using a High-Shear Mixer 142
Effect of Drying Methods on Retention of Moist Sucralfate Gel Properties 142
Les formes pharmaceutiques du futur 142
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 142
Disintegration Propensity of Tablets evaluated by Means of Disintegration Force Kinetics 142
A physical analysis of the phenomenon of tablet disintegration 142
Characterization of the permselective properties of rabbit skin during transdermal iontophoresis 141
Preparation of poly(methacrylic acid-g-poly(ethylene glycol) nanospheres from methacrylic monomers for pharmaceutical applications 141
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 140
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 140
Assembled modules technology for site-specific prolonged delivery of norfloxacin 139
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 138
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation 138
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 137
Dried sucralfate gel retaining the colloidal properties of sucralfate moist gel 136
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 135
Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency 135
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 134
INSULIN HIGHLY RESPIRABLE MICROPARTICLES 134
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 134
Modular systems fitted together for the controlled release of substances 133
New modules, new assembly kits and new assembles for controlled release of substances 132
The use of multilayer poly(vinyl alcohol) adsorption to fabricate drug rich inhalable microparticles. 131
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 131
New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin 130
Effect of electroosmotic flow on permeation and skin accumulation of acyclovir during transdermal iontophoresis 129
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 129
Primary microparticles and agglomerates of morphine for nasal insufflation 128
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 128
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 128
Distribution of khellin in excised human skin following iontophoresis and passive dermal transport 128
Effect of drying methods on retention of moist sucralfate gel properties 128
Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate 128
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 128
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 127
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 127
Assay of acyclovir in human skin layers by high-performance liquid chromatography 127
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 127
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 125
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 124
A new ibuprofen pulsed release oral dosage form 123
Swelling and drug release in hydrogel matrices: Polymer viscosity and matrix porosity effects 123
Drug Release from Swelling-Controlled Systems 122
Film bioadesivo contenente caffeina per il trattamento della cellulite 122
Tapioca starch graft copolymers and Dome Matrix® modules assembling technology. I. Effect of module shape on drug release 122
Back to Basics: The development of a simple, homogenous, two-component dry powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers. 122
Film for active ingredientes dermal and transdermal administration 122
Totale 14.977
Categoria #
all - tutte 124.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/20221.419 17 14 12 62 51 83 154 226 63 95 141 501
2022/20235.025 627 543 297 320 415 575 81 269 1.748 26 98 26
2023/20241.865 81 215 63 88 153 404 151 133 47 135 157 238
2024/20256.028 116 372 438 360 627 668 144 183 795 593 475 1.257
2025/202612.522 1.139 1.213 1.484 1.135 1.857 740 1.506 399 1.603 889 375 182
Totale 35.519